Cha BS

References (3)

Title : A randomized, placebo-controlled, double-blind, phase 3 trial to evaluate the efficacy and safety of anagliptin in drug-naive patients with type 2 diabetes - Yang_2015_Endocr.J_62_449
Author(s) : Yang HK , Min KW , Park SW , Chung CH , Park KS , Choi SH , Song KH , Kim DM , Lee MK , Sung YA , Baik SH , Kim IJ , Cha BS , Park JH , Ahn YB , Lee IK , Yoo SJ , Kim J , Park Ie B , Park TS , Yoon KH
Ref : Endocrine Journal , 62 :449 , 2015
PubMedID: 25819061

Title : Anti-obesity effects of KR-66195, a synthetic DPP-IV inhibitor, in diet-induced obese mice and obese-diabetic ob\/ob mice - Lee_2014_Metabolism_63_793
Author(s) : Lee EY , Kim YW , Oh H , Choi CS , Ahn JH , Lee BW , Kang ES , Cha BS , Lee HC
Ref : Metabolism , 63 :793 , 2014
PubMedID: 24684824

Title : Adenoviral vector-mediated glucagon-like peptide 1 gene therapy improves glucose homeostasis in Zucker diabetic fatty rats - Lee_2008_J.Gene.Med_10_260
Author(s) : Lee Y , Kwon MK , Kang ES , Park YM , Choi SH , Ahn CW , Kim KS , Park CW , Cha BS , Kim SW , Sung JK , Lee EJ , Lee HC
Ref : J Gene Med , 10 :260 , 2008
PubMedID: 18085721